Stay updated on Fazirsiran Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.

Latest updates to the Fazirsiran Safety & Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the previous notices about government funding and operating status (Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding was added, informing users that transactions may not be processed and directing users to cc.nih.gov and opm.gov for updates. A new site revision (v3.4.1) was released, replacing the previous v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedUI updates include showing the glossary option and new labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision updated to v3.4.0. These are minor metadata/UI changes and do not affect core study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe header shows Revision: v3.3.4 (replacing v3.3.3), a non-substantive UI/versioning change that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page reorganizes study sites under a consolidated 'Locations' section, listing the states Alabama, Arizona, California, Florida, Indiana, Iowa, Missouri, New York, South Carolina, Tennessee, Texas, and Utah. The update also adds a revision tag (v3.3.3) and removes the prior per-state 'Locations' subsections, replacing them with the consolidated list.SummaryDifference1%

- Check91 days agoChange DetectedAn addition notes that publications are automatically filled from PubMed and may not all pertain to the study, and a new revision tag v3.3.2 was added. The prior PubMed description and revision tag v3.2.0 were removed.SummaryDifference0.1%

Stay in the know with updates to Fazirsiran Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.